|
1YZK
GppNHp bound Rab11 GTPase
Deposited 2005-02-28
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
8–175(168 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;277 K;NaCl, Glycerol, MES, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 4K
|
Resolution 2.00 Å
R-free 0.228
|
|
2D7C
Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain
Deposited 2005-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
6–172(167 aa)
Fragment:residues 7-173
|
Mutation:Q70L
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 1.75 Å
R-free 0.224
|
|
2D7C
Crystal structure of human Rab11 in complex with FIP3 Rab-binding domain
Deposited 2005-11-16
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
6–172(167 aa)
Fragment:residues 7-173
|
Mutation:Q70L
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 1
GTP GUANOSINE-5'-TRIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6;289 K;20% iso-propanol, 3% (w/v) PEG 4000, 0.05M MES-NaOH, pH 6.0, VAPOR DIFFUSION, HANGING DROP, temperature 289K
|
Resolution 1.75 Å
R-free 0.224
|
|
2GZD
Crystal Structure of Rab11 in Complex with Rab11-FIP2
Deposited 2006-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–172(172 aa)
Fragment:G protein domain
Chain B
1–172(172 aa)
Fragment:G protein domain
|
Mutation:Q70L
Non-standard monomer:Yes (specific site not provided by mmCIF)
Mutation:Q70L
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
MG MAGNESIUM ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5;298 K;Ammonium phosphate buffer, between 0.1 and 0.5 M concentration, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.44 Å
R-free 0.279
|
|
2GZH
Crystal Structure of Rab11 in Complex with Rab11-Family Interacting Protein 2
Deposited 2006-05-11
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
1–172(172 aa)
Fragment:G protein domain
|
Mutation:Q70L
Non-standard monomer:Yes (specific site not provided by mmCIF)
|
PO4 PHOSPHATE ION × 2
MG MAGNESIUM ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5;298 K;Ammonium phosphate buffer, approximately 0.3M concentration, pH 5, VAPOR DIFFUSION, temperature 298K
|
Resolution 2.47 Å
R-free 0.254
|
|
2HV8
Crystal structure of GTP-bound Rab11 in complex with FIP3
Deposited 2006-07-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain A
5–174(170 aa)
Fragment:GTPase domain
|
Mutation:Q70L
|
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.86 Å
R-free 0.237
|
|
2HV8
Crystal structure of GTP-bound Rab11 in complex with FIP3
Deposited 2006-07-27
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 4
PDB declaration: tetrameric
|
Chain B
5–174(170 aa)
Fragment:GTPase domain
Chain C
5–174(170 aa)
Fragment:GTPase domain
|
Mutation:Q70L
Mutation:Q70L
|
MG MAGNESIUM ION × 2
SO4 SULFATE ION × 4
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
2ME METHOXYETHANE × 1
MES 2-(N-MORPHOLINO)-ETHANESULFONIC ACID × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;277 K;20% PEG4000, 0.4M Ammonium Sulfate, 100mM MES, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 277K
|
Resolution 1.86 Å
R-free 0.237
|
|
4C4P
Crystal Structure of Wild-Type Rab11 Complexed to FIP2
Deposited 2013-09-07
|
Different construct
Different mutation/modification
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–173(173 aa)
Fragment:RESIDUES 1-173
|
Not recorded
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
mmCIF provides none of the parsed conditions
|
Resolution 2.00 Å
R-free 0.223
|
|
4D0L
Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS
Deposited 2014-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å
R-free 0.259
|
|
4D0L
Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS
Deposited 2014-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–216(216 aa)
|
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å
R-free 0.259
|
|
4D0L
Phosphatidylinositol 4-kinase III beta-PIK93 in a complex with Rab11a- GTP gammaS
Deposited 2014-04-29
|
Different construct
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–216(216 aa)
|
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.6;15% (W/V) PEG 4000, 0.1 M NA CITRATE PH 5.6, AND 0.2 M AMMONIUM ACETATE
|
Resolution 2.94 Å
R-free 0.259
|
|
4D0M
Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3
Deposited 2014-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain B
1–216(216 aa)
Chain D
1–216(216 aa)
Chain P
1–216(216 aa)
Chain T
1–216(216 aa)
|
Mutation:YES
Mutation:YES
Mutation:YES
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å
R-free 0.359
|
|
4D0M
Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3
Deposited 2014-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain H
1–216(216 aa)
Chain J
1–216(216 aa)
Chain N
1–216(216 aa)
Chain R
1–216(216 aa)
|
Mutation:YES
Mutation:YES
Mutation:YES
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å
R-free 0.359
|
|
4D0M
Phosphatidylinositol 4-kinase III beta in a complex with Rab11a-GTP- gamma-S and the Rab-binding domain of FIP3
Deposited 2014-04-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 12
PDB declaration: dodecameric
|
Chain X
1–216(216 aa)
Chain Z
1–216(216 aa)
Chain d
1–216(216 aa)
Chain h
1–216(216 aa)
|
Mutation:YES
Mutation:YES
Mutation:YES
Mutation:YES
|
093 N-(5-(4-CHLORO-3-(2-HYDROXY-ETHYLSULFAMOYL)- PHENYLTHIAZOLE-2-YL)-ACETAMIDE × 4
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 4
MG MAGNESIUM ION × 4
|
X-RAY DIFFRACTION
X-ray crystallization conditions
16% PEG 6K, 0.01 M NA CITRATE
|
Resolution 6.00 Å
R-free 0.359
|
|
4LWZ
Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a
Deposited 2013-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.55 Å
R-free 0.295
|
|
4LWZ
Crystal structure of Myo5b globular tail domain in complex with inactive Rab11a
Deposited 2013-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;17% peg, 100 mM NaCl, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.55 Å
R-free 0.295
|
|
4LX0
Crystal structure of Myo5b globular tail domain in complex with active Rab11a
Deposited 2013-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded
|
MG MAGNESIUM ION × 1
BEF BERYLLIUM TRIFLUORIDE ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
GOL GLYCEROL × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.19 Å
R-free 0.218
|
|
4LX0
Crystal structure of Myo5b globular tail domain in complex with active Rab11a
Deposited 2013-07-29
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain C
1–177(177 aa)
Fragment:Dilute domain residues 1456-1848
|
Not recorded
|
MG MAGNESIUM ION × 1
BEF BERYLLIUM TRIFLUORIDE ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;298 K;10 % peg, 90 mM NaF, pH 8, VAPOR DIFFUSION, HANGING DROP, temperature 298K
|
Resolution 2.19 Å
R-free 0.218
|
|
4UJ4
Crystal structure of human Rab11-Rabin8-FIP3
Deposited 2015-04-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain D
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain G
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å
R-free 0.266
|
|
4UJ4
Crystal structure of human Rab11-Rabin8-FIP3
Deposited 2015-04-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain J
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å
R-free 0.266
|
|
4UJ4
Crystal structure of human Rab11-Rabin8-FIP3
Deposited 2015-04-08
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 6
PDB declaration: hexameric
|
Chain A
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
Chain J
4–186(183 aa)
Fragment:GTPASE DOMAIN, RESIDUES 4-186
|
Mutation:YES
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 2
MG MAGNESIUM ION × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 5.8;50MM MES PH 5.8, 0.2M AMMONIUM SULFATE AND 14% PEG 8000
|
Resolution 4.20 Å
R-free 0.266
|
|
4UJ5
Crystal structure of human Rab11-Rabin8-FIP3
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
6–186(181 aa)
Fragment:GTPASE DOMAIN, RESIDUES 6-186
|
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
SO4 SULFATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
|
Resolution 2.60 Å
R-free 0.272
|
|
4UJ5
Crystal structure of human Rab11-Rabin8-FIP3
Deposited 2015-04-08
|
Different construct
Different oligomeric state
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
6–186(181 aa)
Fragment:GTPASE DOMAIN, RESIDUES 6-186
|
Mutation:YES
|
GNP PHOSPHOAMINOPHOSPHONIC ACID-GUANYLATE ESTER × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
pH 7;0.1M HEPES PH 7.0, 0.2M LITHIUM SULFATE AND 24% PEG 3350
|
Resolution 2.60 Å
R-free 0.272
|
|
5C46
Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta in complex with GTP gamma S loaded Rab11
Deposited 2015-06-17
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–216(216 aa)
|
Mutation:Q70L
|
SO4 SULFATE ION × 2
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
MG MAGNESIUM ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 2.65 Å
R-free 0.246
|
|
5C4G
Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with the inhibitor BQR695 in complex with GDP loaded Rab11
Deposited 2015-06-18
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Mutation:Q70L
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 2
BQR N~2~-[7-(3,4-dimethoxyphenyl)quinoxalin-2-yl]-N-methylglycinamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 3.20 Å
R-free 0.287
|
|
5EUQ
Crystal structure of an engineered construct of phosphatidylinositol 4 kinase III beta with a potent and selective inhibitor in complex with GDP loaded Rab11
Deposited 2015-11-19
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Insufficient information
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
SO4 SULFATE ION × 2
5S8 ~{N}-[5-[3-[[(4-hydroxyphenyl)amino]-bis(oxidanyl)-$l^{4}-sulfanyl]-4-methoxy-phenyl]-4-methyl-1,3-thiazol-2-yl]cyclopentanecarboxamide × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION;pH 5.6;290 K;PEG-4000, sodium citrate, ammonium sulfate, glycerol
|
Resolution 3.20 Å
R-free 0.266
|
|
5EZ5
Crystal structure of active Rab11A (S20V) in complex with GTP
Deposited 2015-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
8–175(168 aa)
Fragment:UNP residues 8-175
Chain B
8–175(168 aa)
Fragment:UNP residues 8-175
|
Mutation:S20V
Mutation:S20V
|
MG MAGNESIUM ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Sodium chloride, Tris, Magnessium chloride
|
Resolution 2.40 Å
R-free 0.304
|
|
5EZ5
Crystal structure of active Rab11A (S20V) in complex with GTP
Deposited 2015-11-26
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein homooligomer
Homooligomer;Protein × 2
PDB declaration: dimeric
|
Chain A
8–175(168 aa)
Fragment:UNP residues 8-175
Chain B
8–175(168 aa)
Fragment:UNP residues 8-175
|
Mutation:S20V
Mutation:S20V
|
MG MAGNESIUM ION × 2
GTP GUANOSINE-5'-TRIPHOSPHATE × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;Sodium chloride, Tris, Magnessium chloride
|
Resolution 2.40 Å
R-free 0.304
|
|
5FBL
PI4KB in complex with Rab11 and the MI356 Inhibitor
Deposited 2015-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
5W9 ~{N}-[2-[[6-chloranyl-3-(4-methoxy-3-morpholin-4-ylsulfonyl-phenyl)-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;1M Lithium chloride, 0.1M Citric acid pH=5, 10% (w/v) PEG 6000
|
Resolution 3.37 Å
R-free 0.269
|
|
5FBQ
PI4KB in complex with Rab11 and the MI358 Inhibitor
Deposited 2015-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
5W6 ~{N}-[2-[[6-chloranyl-3-[3-[4-(hydroxymethyl)piperidin-1-yl]sulfonyl-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.2M magnesium chloride, 0.1M Tris PH=7, 10% (w/v) PEG 8000
|
Resolution 3.79 Å
R-free 0.302
|
|
5FBR
PI4KB in complex with Rab11 and the MI359 Inhibitor
Deposited 2015-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
5W7 ~{N}-[2-[[3-[3-[(4-azanylcyclohexyl)sulfamoyl]-4-methoxy-phenyl]-6-chloranyl-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.15M amonium sulfate, 0.1M MES pH=6, 15% PEG 4000
|
Resolution 3.28 Å
R-free 0.264
|
|
5FBV
PI4KB in complex with Rab11 and the MI364 Inhibitor
Deposited 2015-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
5W3 ~{N}-[2-[[6-chloranyl-3-[3-(2-hydroxyethylsulfamoyl)-4-methoxy-phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethy l]ethanamide × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.15M amonium sulfate, 0.1M MEW pH=6, 15% PEG 4000
|
Resolution 3.29 Å
R-free 0.281
|
|
5FBW
PI4KB in complex with Rab11 and the MI369 Inhibitor
Deposited 2015-12-14
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Not recorded
|
5W8 ~{N}-[2-[[6-chloranyl-3-[4-methoxy-3-[[(2~{R})-1-oxidanylbutan-2-yl]sulfamoyl]phenyl]-2-methyl-imidazo[1,2-b]pyridazin-8-yl]amino]ethyl]ethanamide × 1
GSP 5'-GUANOSINE-DIPHOSPHATE-MONOTHIOPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;291 K;0.2M ammonium sulfate, 0.1M MES pH=6.5, 20% (w/v) PEG 8000
|
Resolution 3.49 Å
R-free 0.283
|
|
5JCZ
Rab11 bound to MyoVa-GTD
Deposited 2016-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–177(177 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
BEF BERYLLIUM TRIFLUORIDE ION × 1
EDO 1,2-ETHANEDIOL × 5
ACT ACETATE ION × 1
GOL GLYCEROL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å
R-free 0.208
|
|
5JCZ
Rab11 bound to MyoVa-GTD
Deposited 2016-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain D
1–177(177 aa)
|
Not recorded
|
MG MAGNESIUM ION × 2
GDP GUANOSINE-5'-DIPHOSPHATE × 1
BEF BERYLLIUM TRIFLUORIDE ION × 1
EDO 1,2-ETHANEDIOL × 6
ACT ACETATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å
R-free 0.208
|
|
5JCZ
Rab11 bound to MyoVa-GTD
Deposited 2016-04-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain I
1–177(177 aa)
|
Not recorded
|
MG MAGNESIUM ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
BEF BERYLLIUM TRIFLUORIDE ION × 1
EDO 1,2-ETHANEDIOL × 2
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;290 K;7% (w/v) PEG-8000, 50 mM Bicine, 50 mM Tris, 30mM sodium fluoride, 20% (v/v) ethylene glycol
|
Resolution 2.06 Å
R-free 0.208
|
|
6DJL
Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A
Deposited 2018-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain A
1–216(216 aa)
|
Mutation:Q70L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å
R-free 0.278
|
|
6DJL
Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A
Deposited 2018-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–216(216 aa)
|
Mutation:Q70L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å
R-free 0.278
|
|
6DJL
Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A
Deposited 2018-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
1–216(216 aa)
|
Mutation:Q70L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å
R-free 0.278
|
|
6DJL
Crystal structure of the Rab11 GEF SH3BP5 bound to nucleotide free Rab11A
Deposited 2018-05-25
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–216(216 aa)
|
Mutation:Q70L
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.5;289 K;23% PEG-3350, 200 mM NaCl, 100 mM Bis Tris pH-6.5
|
Resolution 3.10 Å
R-free 0.278
|
|
6IXV
Crystal structure of SH3BP5-Rab11a
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain E
1–173(173 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å
R-free 0.259
|
|
6IXV
Crystal structure of SH3BP5-Rab11a
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain F
1–173(173 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å
R-free 0.259
|
|
6IXV
Crystal structure of SH3BP5-Rab11a
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain G
1–173(173 aa)
|
Not recorded
|
No recorded non-water small molecule
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å
R-free 0.259
|
|
6IXV
Crystal structure of SH3BP5-Rab11a
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain H
1–173(173 aa)
|
Not recorded
|
PO4 PHOSPHATE ION × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, SITTING DROP;293 K;0.6M NaCl, 0.1M NaH2PO4 pH 6.8, 16% PEG 2000
|
Resolution 3.80 Å
R-free 0.259
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain A
9–173(165 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 2
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain B
9–173(165 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 3
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain C
9–173(165 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 4
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain D
7–173(167 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 5
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain E
9–173(165 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
6IY1
Structure of human Ras-related protein Rab11
Deposited 2018-12-12
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 6
Protein monomer
Monomer;Protein × 1
PDB declaration: monomeric
|
Chain F
6–173(168 aa)
|
Not recorded
|
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;293 K;0.15M Li2SO4, 0.1M Glycine, 0.8M NaH2PO4
1.2M Na2HPO4
|
Resolution 2.11 Å
R-free 0.261
|
|
8VOF
GI targeted CpPI4K inhibitor
Deposited 2024-01-15
|
Different construct
Different mutation/modification
Different oligomeric state
Different ligand/ion
Different experimental conditions
Different structure-quality metrics
|
Assembly 1
Protein heterocomplex
Heteromer;Protein × 2
PDB declaration: dimeric
|
Chain B
1–216(216 aa)
|
Mutation:Q70L
|
A1ADE methyl 2-chloro-5-(methyl{(8R)-3-[4-(methylcarbamoyl)phenyl]pyrazolo[1,5-a]pyridine-5-carbonyl}amino)benzoate × 1
SO4 SULFATE ION × 1
GDP GUANOSINE-5'-DIPHOSPHATE × 1
|
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 8;294 K;0.5M ammonium sulfate, 0.088M sodium citrate, 0.875M lithium sulfate, 2.4% glycerol, 2.5% ethylene glycol, 50mM HEPES pH 6.8
|
Resolution 3.00 Å
R-free 0.270
|